"A subsidiary of Open Orphan, hVIVO is an industry leading services provider in viral challenge studies and laboratory services supporting product development for customers developing antivirals, vaccines and respiratory therapeutics."

During the past decade, hVIVO Services Limited conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "hVIVO Services Limited" #1 sponsor was "Hvivo" with 2 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored, "Cidara Therapeutics Inc." with 1 trials sponsored and "Codagenix, Inc" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "hVIVO Services Limited" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "Hvivo" with 1 trials as a collaborator, "Janssen Pharmaceuticals" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "hVIVO Services Limited" are "RSV Infection" (3 trials), "Healthy" (2 trials), "Influenza" (2 trials), "Respiratory Syncytial Virus Infections" (2 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "hVIVO Services Limited" in a lesser frequency.

Most popular intervention types in "hVIVO Services Limited" are "Drug" (10 trials), "Other" (7 trials), "Biological" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ad26.RSV.preF" (1 trials), "CD388" (1 trials), "COVI-VAC" (1 trials) and "Challenge virus RSV-A Memphis 37b" (1 trials). Other intervention names were less common.

The vast majority of trials in "hVIVO Services Limited" are 15 trials for "All" genders.

Currently, there are NaN active trials in "hVIVO Services Limited". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in hVIVO Services Limited, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in hVIVO Services Limited, 5 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".